`COMMISSION, OFFICE OR BUREAU
`
`Form 5
`Rev. 03/16
`
`UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
`
`E. I. DuPont De Nemours and
`Company and Archer-Daniels-
`Midland Company
`
`Petitioner or Appellant,
`
`PETITION FOR REVIEW
`
`Furanix Technologies B.V.
`
`Respondentor Appellee.
`
`E. J. DuPont De Nemours and Company and
`Archer-Daniels-Midland Company
`
`(nameall parties* bringing the petition or appeal).
`
`(describe
`
`(Address, phone numberand e-mail ofpetitioner, appellant or attorney)
`
`hereby petition/appeal the court for review of the Final Written-Decision, Paper No. 43, IPR2015-01838
`the order or decision and inciude decision number) of the U.S. Patent and Trademark Office
`(mame the agency, board, office or bureau) entered on Mar3, 2017
`(date).
`The order or decision was received on Mar3, 2017
`(date).
`
`/s/ Michael S. Marcus
`Date: May 2, 2017
`é+Ane
`(Signatureof petitioner, appellants
`“3
`—w
`or attorney)
`8
`Blank Rome LLP
`
`1825 Eye Street NW
`
`Washington, DC 20006°
`
`(202) 420-2200, MMarcus@BlankRome.com
`
`*SeeFed. R. App. P. 15 (a) (2)-for-permissible ways of identifying petitioners.
`
`
`
`FORM 380. Certificate ofService
`
`Form 30
`Rev, 03/16
`
`UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
`
`
`
`q
`
`CERTIFICATE OF SERVICE
`
`I certify that I served a copy on counsel of record on May2, 2017
`by:
`
`C U.S. Mail
`
`C] Fax
`
`| Hand
`Electronic Means(by E-mail or CM/ECF)
`
`Michael S. Marcus
`
`‘
`
`/s/ Michael S. Marcus
`
`Nameof Counsel
`
`Signature of Counsel
`
`Law Firm
`
`Address
`
`Blank Rome LLP
`
`1825 Eye Street NW
`
`City, State, Zip
`
`Washington, DC 20006
`
`Telephone Number
`
`(202) 420-2200.
`
`Fax Number
`
`202) 420-2201
`
`E-Mail Address
`
`MMarcus@BlankRome.com
`
`
`
`NOTE: For attorneys filing documents electronically, the name of the filer under whose log-in and
`lpassword a document is submitted must be preceded by an "/s/" and typed in the space where the
`signature would otherwise appear. Graphic and otherelectronic signatures are discouraged.
`
`| ResetFields
`
` -
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`E. I. DU PONT DE NEMOURS AND COMPANY and
`ARCHER-DANIELS-MIDLAND COMPANY,
`Petitioners,
`
`Vv.
`
`FURANIX TECHNOLOGIESB.V.,
`Patent Gwner.
`
`Case IPR2015-01838
`Patent 8,865,921 B2
`
`PETITIONERS’ NOTICE OF APPEAL
`
`
`
`
`
`Pursuant to 35 U.S.C. § 142 and 37 C.F.R. 90.2(a), Petitioners E. I. du
`Pont de Nemours and Company and Archer-Daniels-Midland Company
`(collectively, “Petitioners”) hereby givenotice oftheir appeal under 35 U.S.C.
`§ 141(c) to the United States Court ofAppeals for the Federal Circuit from the
`
`Final Written Decision (Paper 43) issued by the Patent Trial andAppeal Board
`(“the Board”) on March 3, 2017 in the above-captioned proceeding, and from
`
`all other orders, decisions, rulings, and opinions underlyingorrelated to the
`
`Final Written Decision.
`
`In accordance with 37 C.F.R. § 90.2(a)(3)(i1), the expected issues on
`
`appeal include, but are not limited to, the Board’s failure to construe the
`disputed claim terms; its misapplication ofthe law of obviousnessin the
`
`context of overlapping ranges; and its decision that Petitioners did not show by
`
`a preponderanceof the evidence that claims 1-5 and 7-9 of U.S. Patent
`
`8,865,921 B2 are unpatentable as obvious under 35 U.S.C. § 103(a) and any
`
`finding or determination supporting orrelating to that issue, as well as all other
`
`issues decided adversely to Petitioners or not considered in any orders,
`
`decisions, rulings, or opinions.
`This Notice ofAppeal isbeing filed simultaneously withthe Director of
`
`the United States Patent and Trademark Office, the Board, and the Clerk’s
`
`
`
`Office for the United States Court of Appeals for the Federal Circuit.
`
`Dated: May 2, 2017
`
`/Michael S. Marcus/
`
`By:
`Michael S. Marcus
`Registration No.: 31,727
`Dipu.A. Doshi
`Registration No.: 60,073
`Jonathan W.S. England
`Registration No.: 71,223
`BLANK ROME LLP
`1825 Eye Street, NW
`Washington, DC 20006-5403
`(202) 420-2200
`Attorneys for Petitioners
`
`
`
`‘CERTIFICATE OF FILING
`
`Pursuant to 37 C.F.R. § 104.2, the undersigned certifies that, in addition to
`
`being filed electronically through the Patent Trial and Appeal Board End to End
`system, theoriginal version ofthe foregoing PETITIONERS’ NOTICE OF
`APPEAL-was filed with the Director ofthe United States Patent and Trademark
`
`Office at the following address:
`
`‘
`
`Director of the United States Patent and Trademark Office
`
`c/o Office of the General Counsel
`
`Madison Building East, 10B20
`
`600 Dulany Street
`
`Alexandria, Virginia
`
`The undersigned also certifies that a copy of the foregoing PETITIONERS’
`
`NOTICE OF APPEAL,andthe filing fee, were filed with the Clerk’s Office for
`
`the United States Court of Appeals for the Federal Circuit via CM/ECF.
`
`
`
`CERTIFICATE OF FILING
`
`The undersignedcertifies that a copy of the foregoing PETITIONERS’
`
`NOTICE OF APPEAL is being served on counsel of record by electronic mail.
`
`Dated: May 2, 2017
`
`/Jonathan W.S. England/
`
`By:
`Jonathan W.S. England
`Registration No.: 71,223
`BLANK-ROME LLP
`1825 Eye Street, NW
`Washington, DC 20006-5403
`(202) 420-2200
`Attorney for Petitioner
`
`
`
`EXHIBIT 1
`
`
`
`Trials@uspto.gov
`571-272-7822
`
`Paper No. 43
`Entered: March 3, 2017
`
`UNITED STATES PATENT AND FRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`E. I. DU PONT DE NEMOURS AND COMPANY AND
`ARCHER-DANIELS-MIDLAND COMPANY,
`Petitioners,
`
`V.
`
`FURANLX TECHNOLOGIESB.V.,
`Patent Owner.
`
`Case IPR2015-01838
`Patent 8,865,921 B2
`
`Before TONI R. SCHEINER, SHERIDAN K. SNEDDEN and
`CHRISTOPHER G. PAULRAJ, Administrative Patent Judges.
`
`PAULRAJ, Administrative Patent Judge.
`
`FINAL WRITTEN DECISION
`35 US.C. § 318(a) and 37 CFR. § 42.73
`
`
`
`‘ IPR2015-01838
`Patent 8,865,921 B2
`
`I.
`
`INTRODUCTION
`
`E. E. du Pont de Nemours and Company and Archer-Daniels-Midland
`Company (collectively, Petitioners’) filed a Petition (Paper 1, “Pet.”),
`requesting institution of an inter partes review of claims 1-10 of
`U.S. Patent No. 8,865,921 B2 (Ex. 1001, “the ’921 Patent”). Furanix
`
`Technologies B.V. (“Patent Owner”) did notfile a Preliminary Response.
`Wehave jurisdiction under 35 U.S.C. § 314, which provides that an inter
`partes review may notbeinstituted “unless .
`.
`. there is a reasonable
`likelihoodthat the petitioner would prevail with respectto at least 1 of the
`claims challenged in the petition.” We determined that the information
`presented in the Petition demonstrated that there was a reasonable likehhhood
`that Petitioners wouldprevail in challenging claims 1-5 and 7—9 as
`unpatentable under 35 U.S.C. § 103(a). Pursuant to-35 U.S.C. § 314, the
`Boardinstituted trial on March 9, 2016, as to those claims ofthe ‘977 Patent.
`
`Paper 10 (“Institution Decision”; “Inst. Dec.”). We denied Petitioners’
`request for rehearing of our decision-to deny institution as to the
`patentability challenge for claims 6 and 10. Paper 20.
`Following ourinstitution, Patent Ownerfiled a Response to the
`Petition. Paper 23 (“PO Resp.”). Petitioners filed aReply to Patent
`Owner’s Response. Paper 29 (“Reply”). An oral hearing was held on
`November16, 2016. The transcript ofthe hearing has been entered into the
`record. Paper 42 (“Tr.”).
`|
`|
`Wehavejurisdiction under 35 U.S.C. § 6. This Final Written
`Decision is issued pursuant to 35 U.S.C. § 318({a) and 37 C.F.R. § 42.73.
`Based on the record before us, we conclude that Petitioners have not
`demonstrated by a preponderanceofthe.evidencethat claims 1-5 and 7-9 of
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`the °921 Patent are unpatentable based on the obviousness challenges
`
`presented in the Petition.
`A.
`Related Proceedings.
`The parties have notidentified any separate related matters under 42
`C.F.R. § 42.8(b)(2). Pet. 1; Paper5, 1.
`
`B.
`The ’921 Patent (Ex. 1001)
`The °921 patent issued on October 21, 2014, and claimspriority to a
`provisional application filed on October 7, 2009. See Ex. 1001, Title Page.
`It names Cesar Mufioz De Diego, Matheus Adrianus Dam, and Gerardus
`Johannes Maria Gruter as the inventors. Jd.
`
`.
`
`The ’921 patent relates generally to methods forpreparing 2, 5-furan
`dicarboxylic acid (FDCA), or a dialkyl ester of FDCA,by contacting 5-
`hydroxymethylfurfural (HME), and/or derivativesthereof, with an-oxygen-
`containing gas in.the presence of oxidation catalysts comprising cobalt.(Co),
`manganese(Mn), and bromine (Br) (i.e., a Co/Mn/Brcatalyst), and an acetic
`acid solvent at elevated temperatures. Id., Abstract, 1:18-26, 2:39-45. The
`°921 patent states that “FDCA can be producedin particular from esters of
`HME,suchas for example 5-acetoxymethylfurfural (AMF) or a mixture of
`one or more of thesé compounds with HMF,such as for example from a
`mixture of AMF and HMF.” Jd. at 1:21—-24. The ’921 patent further
`
`discusses the use of FDCA obtained accordingto the process described
`therein to prepare a dialkyl ester of 2,5-dicarboxylic acid by the reaction of
`FDCA with a Ci-Cs alkyl alcohol. Jd. at 5:20-41. The°921 patent
`acknowledges that the esterification ofFDCA was knownin thepriorart.
`Id. at 5:42-58.
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`According to'the 921 patent, FDCA has beenidentified as a priority
`chemical for establishing a “green” chemistry industry, but no commercial
`process exists for its production. Id. at 1:34-38. The.specification states.
`that FDCA, a furan derivative, is often synthesized inthe laboratory from
`HME obtained from carbohydrate containing sources such-as glucose,
`fructose, sucrose, and starch. Id. at 1:30-43. The derivatives of HME are
`known to bepotential and versatile fuel components and precursors for the
`production ofplastics. Jd. at 1:44-46. The specification identifies prior art
`processes for the oxidation of HMF to FDCA with a Co/Mn/Brcatalyst at
`temperatures ranging from 50 to 125°C, which resulted in low reactivity or
`yield loss. Id. at 1:48-67, 2:1-35. The '921 patent seeks to improve prior
`art yields by controlling the temperature and/or pressure under which the
`oxidation reaction occurs. Id. at 4:34-61.
`In-particular, the °921 patent specification explainsthat “[t]he pressure
`in a commercial oxidation process may vary within wide ranges,” and “is
`determined by the solvent (e.g., acetic acid) pressure at a certain
`temperature.” Id. at 4:34-39. Moreover, the pressure is preferably selected
`to maintain the solvent in the liquid phase, which “meansthat pressures
`‘between 5 and 100 bar can be used with a preference for pressures between
`10 and 80 bar.” Jd. at 4:39-43. The oxidant can be an oxygen-containing
`gas, such as air, which “can be continuously fed to and removed from the
`reactor,” in which case “the oxygen partial pressure will suitably be between
`1 and 30 bar or more preferably between 1 and 10 bar.” Id. at 4:43-46, 51—
`55. Conversely, all of the oxygen-containinggas can be-supplied at the start
`of the reaction, but this will require a significantly higher pressure. Jd. at
`4:45-51. The specification further explains that“[t]he temperature of the
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`reaction mixtureis at least 140° C., preferably from 140 and 200° C., most
`preferably between 160 and 190° C.” Id. at 4:56-58. The specification
`notes that “Eg]ood results” were achieved at about 180°C,but cautions that
`“It]emperatures higher than 180° C may lead to decarboxylation andto other
`degradation products.” Jd. at 4:58-61.
`The ’921 patent includes working examples describing experiments in
`which the oxidation reaction was carried out with a Co/Mn/Brcatalystat an
`
`air pressure ranging from 20-60 bars and temperatures ranging from 100 to
`220°C. Id. at 6:8-11. More particularly, Example 1 describes the oxidation
`of HME and/or AMF at 180°C for 1 hour with 20 bar air pressure, which
`resulted in FDCAyields of up to 78.08%. Id. at 6:34-46, Table 1. Example
`2 provides a comparative example in which AMF oxidation was conducted
`at 100°C and 30 bar for 2 hours, showing that FDCA yields under those
`
`conditions were lower than the results obtained at higher temperature. /d. at
`
`6:50-62, Table 2.
`
`C. Illustrative Claims
`
`Claims 1-5 and 7-6 are challengedin this inter partes review.
`
`Independent claim1isillustrative, and reproduced below:
`
`1. A methodforthe preparation of 2,5-furan dicarboxylic acid
`comprising the step of contacting a feed comprising a compound
`selected from the group consisting of 5-hydroxymethylfurfural
`(“MF”), an ester of 5S-hydroxymethylfurfural, 5-methylfurfural, 5-
`(chloromethy!)furfural, 5-methylfuroic acid, 5-(chloromethyl)furoic
`acid, 2,5-dimethylfuran and a mixture of two or moreof these
`compounds with an oxygen-containing gas, in the presence of an
`oxidation catalyst comprising both Co and Mn,andfurther a source of
`bromine, at a temperature between 140° C and 200° C at an oxygen .
`partial pressure of 1 to 10 bar, wherein a solvent or solvent mixture
`comprising acetic.acid or acetic acid and water mixturesis present.
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`Independentclaim 7 isdirected to the preparation of a dialkyl ester of
`FDCA,and additionally recites the step of “esterifying the thus obtained
`
`product.”
`
`
`
`
`
`§ 103(a)
`
`D. Patentability Challenges
`The following patentability challenges are at issue in this proceeding:
`
`References
`ao ‘Basis _ ~..
`| Claims challenged -
`The °732 publication,‘RU
`mee
`°177,? and the *318 application?
`The °732 publication,
`
`
`Lewkowski,’ Oae,° RU 7177,
`and the °318 application
`
`
`In addition to theteachingsof the references, Petitioners rely upon the
`
`oe
`
`
`
`7-9
`
`Declarations of Kevin J. Martin, Ph.D. (Ex. 1009; Ex. 1028) in support of
`
`these challenges.
`
`1 Grushin et al., WO 01/72732 A2, published Oct. 4, 2001 (Ex. 1002).
`2 Slavinskayaet al., USSR Patent RU-448177A1, published Oct. 30, 1974
`(Ex. 1007, with certified English translation).
`3 Lilga et al., US 2008/0103318 Al,published May 1, 2008 (Ex. 1008).
`4 Lewkowski, Synthesis, Chemistry and Applicationsof5-
`Hydroxymethylfurfural and its Derivatives, ARKIVOC 2001 (i) 17-54,
`Published Online on Aug. 8, 2001 (Ex. 1005).
`> Oae etal., A Study ofthe Acid Dissociation ofFuran- and
`Thiophenedicarboxylic Acids and ofthe Alkaline Hydrolysis of Their Methyl
`Esters, SOC. JPN. 1965, 38, Aug. 1965, at 1247 (Ex. 1006).
`
`6
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`fl.
`
`DISCUSSION
`
`A. Claim Construction
`
`Weinterpret claims of an unexpired patent using the “broadest
`_ reasonable constructionin light of the specification of the patent in which
`[they] appear[}.” 37 C.F.R. § 42.100(b); Cuozzo Speed Techs., LLC v. Lee,
`136 S. Ct. 2131, 2146 (2016). Underthe broadest reasonable construction
`standard, claim terms are given their ordinary and customary meaning,as
`would be understood by one of ordinary skill in the art at the time of the
`
`invention. In re Translogic Tech., Inc., 504 F.3d 1249, 1257 (Fed. Cir.
`
`2007). “Absent claim language carrying a narrow meaning, the PTO should
`only limit the claim based on thespecification .
`.
`. when[it] expressly
`disclaim[s] the broaderdefinition.” In re Bigio, 381 F.3d 1320, 1325 (Fed .
`Cir. 2004). “Although an inventor is indeed free to define the specific terms.
`
`used to describehis or her invention, this must be done with reasonable
`
`clarity, deliberateness, and precision.” Jn re Paulsen, 30 F.3d 1475, 1480
`(Fed. Cir. 1994).
`.
`Wedeterminethat no explicit construction of any claim term is
`
`necessary to resolve the issues in this case. See, e.g., Wellman, Inc. v.
`
`Eastman Chem. Co., 642 F.3d 1355, 1361 (Fed. Cir. 2011) (“[C]laim terms
`
`need only be construed ‘to the extent necessary to resolve the
`controversy.’”) (quoting Vivid Techs., Inc. v. Am. Sci. & Eng’g, Inc.,
`200-F.3d 795, 803(Fed. Cir. 1999)).
`
`B. Prior Art Relied Upon
`
`Petitioners rely upon the following priorart in their challenges.
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`1. The ’732 publication (Ex. 1002)
`The ’732 publication describes the oxidation of HMF to FDCA,and
`the subsequent decarbonylation to unsubstituted furan. Ex. 1002, Title,
`2:17-20.° Thecatalyst used for the oxidation process described in the ’732
`publication “can be comprised of Co and/or Mn,and Br,and optionally
`[zirconium,] Zr.” Jd. at 6:22-24. Acetic acid is identified as a preferred
`solvent because FDCAis insolublein it, thereby facilitating purification. Id.
`
`.
`at 9:14—21.
`The ’732 publication explains furtherthat “[fJor preparation of diacid,
`the preferred temperatures are about 50° to 250°C, most preferentially about
`50° to 160°C,” and “[t]he corresponding pressure is such to keep the solvent
`mostly in the liquid phase.” Jd. at 8:2-5. The ’732 publication discloses
`examples wherein “[p]lacing HMF in reactors with acetic acid and catalyst
`metals and havingthem react with air at 1000 psi (7 MPa) gave goodyields
`
`of FD[C]A.”. Id. at 16:3-4. In Examples 38-40, “the temperature-was
`staged — initially it was held at 75°C for 2 hrs. and then raised to 150°C for
`two hrs,” which “gave higher yields.” Id. at 16:13-15, Table 4.
`The ’732 publicationis identified as prior art in the background
`section ofthe °921 patent, which indicates that “[t]he maximum FDCAyield
`
`reported is 59%, obtained at 105° C.” Ex. 1001, 1:48-50.
`
`6 The ’732 publication uses the acronym “FDA”for 2,5-furan dicarboxylic
`acid. For the sake of consistency, we will refer to the compound as FDCA.
`Wealsorefer herein to the page numbers addedto the very bottem of the
`exhibit (e.g., “Pefitioners’ Exhibit 1002, Page 2 of 23”).
`
`8
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`2. RU’177 (Ex. 1007)
`RU °177 is an “Inventor’s Certificate” issued by the former Union of
`
`Soviet Socialist Republics (USSR), which also teaches a method for
`producing FDCA. Ex. 1007, Title. Specifically, RU °177 claims aprocess
`ef producing FDCAusing air oxidation wherein “5-methylfurfural [SMF] is
`subject to oxidation and mixed valance metalsalts, such as a mixture of
`cobalt acetate and manganeseacetate, as well-as bromine-containing
`compounds, such as-ammonium bromide,in the aliphatic carboxylic acid
`solution are used as a catalyst.” Id. at 2, col. 4 (claim 1). RU°177 also
`includes a claim specifying that the “oxidation is conductedatthe
`temperature of 115—140°C andair pressure of 10—SO atm.” Jd. at 2, col. 4
`(claim 2). RU ’177 further discloses that oxidationis “typically conducted
`under 145-140°C andair pressure of 10-15 atm.” Jd. at 1, col. 1. In
`Example 1 of RU ’177, SMF was reacted at 118°C-and 20 atm ofpressure
`(4.26 bar pO2) for 4.5 hours andthen the temperature was increased to
`130°C and pressure increased to 30 atm (6.38 bar pO2). Id. at 2, col. 3.
`RU °177 states the methoddisclosed therein has a numberof
`advantages,i.e., “it utilizes readily available and inexpensive reagents as the
`initial compoundandcatalysts [and] the method is a one-step process.” Id.
`
`at 1, col. 2.
`
`3. The ’318 application (Ex. 1008)
`The °318 application also relates to a method of oxidizing HMF to
`produce various derivatives, including FDCA. Ex. 1008 7 3. More
`specifically, the °318 application teachesthat“(t]he starting material
`comprising HMF is providedinto a reactor andat least oneofair or Ois.
`- provided as oxidant.” Id. 450. The’318 application indicatesthat,
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`depending upon the desired reactionrate, the pressure utilized may range
`from atmospheric pressureto the pressure rating of the equipment, and “[a]
`preferred pressure can typically be in the rangeof 150-500 psi.” Id.
`“Similarly an appropriate reaction teraperature can be from about 50° C to
`about 200° C, with apreferred range of from 100° C through about 160° C.”
`
`Ia.
`
`The °318 application states that “underparticular reaction conditions,
`HME conversions of 100% were achieved with selectivity to FDCA as high
`as 98% relative to all other reaction products, intermediates and
`byproducts.” Jd. § 55. In Example 1, 98% FDCA selectivity was achieved
`using a Pt/ZrO> catalyst under conditions of 150 psi pressure and 100°C
`temperature. Id. {{ 67-68.
`4. Lewkowski (Ex. 1005)
`Lewkowski discusses the methodsof synthesis of FDCA,and its
`chemistry and application. Ex. 1005, 17. Lewkowski states “(t]he synthesis
`of diethyl ester and dimethyl ester .
`.
`. have been reported.” Jd. at 44.
`Lewkowski cites Oae (Ex. 1006) for the synthesis process of dimethy!ester.
`Id. Lewkowski discloses that the diethyl ester of FDCA has “a strong
`anaesthetic action similar to cocaine,” and that another ester form of
`FDCA—dicalcium 2,5-furandicarboxylate—was shownto haveantibacterial
`
`activity. Id. at 45.
`
`5. Oae (Ex. 1006)
`Oaerelates to the acid dissociation of furandicarboxylic acids and the
`alkaline hydrolysis of their methyl esters. Ex 1006, 1247. Specifically,
`Oae states that dimethyl esters of FDCA were synthesized: in the following
`manner: “Dicarboxylic-acid (0:064 mol.) was refluxed with 10 ml. of
`
`10
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`anhydrous methanolin a benzene sohition with one or two drops of
`concentrated sulfuric acid for several hours,” and “[a]fter the removal of the
`
`excess methanol, the residual dimethyl ester was recrystallized from a
`suitable solvent several times to give the correct melting-point.” Jd. at
`1249. This method yielded 68.7% dimethyl 2,5-furandicarboxylate. Id.
`6. Partenheimer (Ex. 1003)’
`.
`Partenheimeris cited and discussed in-the backgroundsection ofthe
`921 patent. Ex. 1001, 1:55-2:6. Partenheimer describes synthesis of 2,5-
`diformylfuran and FDCAbycatalytic air-oxidation of HMF. Ex. 1003, 102.
`(Title). Specifically, Partenheimer teaches synthesis of FDCA by contacting
`HMEF in the-presence of Co/Mn/Brcatalysts-Co, and with an air pressure of
`70 bar at temperatures up to 125°C. Jd. at 105 (Table 3).
`According to Partenheimer, the advantages of-the oxidation process
`described therein are 1) “that-the catalyst is composed of inexpensive,
`simple metal acetate salts and a-source of ionic bromide (NaBr, HBr, etc.),”
`
`7 Partenheimeretal., Synthesis of2, 5-Diformylfuran and Furan-2, Jj-
`Dicarboxylic Acid by Catalytic Air-Oxidation of5-Hydroxymethylfurfural.
`Unexpectedly Selective Aerobic Oxidation ofBenzyl Alcoholto
`Benzaldehyde with Metal/Bromide Catalysts, 343 ADV. SYNTH. CATAL. 102—
`111, Published Online on Feb. 6, 2001 (Ex. 1003) (“Partenheimer”).
`Although Partenheimerdid not form the basis for the specific patentability
`challenges upon whichweinstitutedtrial, both Petitioners and Patent Owner
`haverelied upon Partenheimer’s teachings to support their respective
`-arguments. See Pet. 15-16; PO Resp. 3, 8, 10, 20, 26-28; Reply 7, 10-12,
`19. We, therefore, consider Partenheimeras relevant “background”art in
`our evaluation of Petitioners’ patentability challenges. See Ariosa
`Diagnostics v. Verinata Health, Inc., 805 F.3d 1359, 1365 (Fed. Cir. 2015)
`(“Art can legitimately serve to document the knowledge that skilled artisans
`would bring to bear in readingthe priorart identified as producing
`obviousness.”).
`
`11
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`2) “t]he reaction times are within a few hoursat easily accessible
`temperatures,” and 3) “[t]he acetic acid solvent is inexpensive and nearly all
`alcohols are highly solublein it.” Id. at 106. Partenheimerteaches. thatthe
`reactions are performedat air pressure of 70 bar and-cautionsthat“[t]he use
`of high pressures and the use of dioxygen/nitrogen mixtures is potentially
`explosive and dangerous,” and “should be performed only with adequate
`barriers for protection.” Id. at 110.
`
`C. Level ofOrdinary Skill in the Art
`
`Petitioners’ expert Dr. Martin. opines that “one of ordinary skill in the
`art of oxidation of aromatic compounds, such as furan based compounds,is
`a person with a doctorate degree in chemistry and/or chemical engineering
`and having at least 5 years of experience in oxidation catalysis and chemical
`process development.” Ex. 1009 14. Patent Owner contends that a person
`of ordinary skill in the art (‘POSA”or“skilled artisan”) for the °921 patent
`would have had “at least.a bachelor’s degree in chemistry-or chemical
`engineering, having workedin the field of chemical process developmentfor
`at least five years and having experience in the preparation offuran
`compounds from biomassandin the catalysis of oxidation of furan
`compoundsfor a similar period.” PO Resp.14 (citing Ex. 2003 4 44). In its
`Reply,Petitioners contend that Patent Owner’s proposedlevel of skill in the
`art places too manylimitations, “whereas Petitioner’s hypothetical POSA —
`as defined by Dr: Martin — would have the knowledge and experience to
`understand that catalyst concentration is a result-effective variable that
`impacts yield.” Reply 2 (citing Ex. 1028 { 7).
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`Although wedonot discern a significant difference between the
`qualifications for a skilled artisan proposed by the parties, we determine that
`Patent Owner’s proposedlevel ofskill in the art is more appropriate for our
`analysis. Specifically, we determinethat a skilled artisan need not have a
`doctorate degree. Patent Owner’s expert, Dr. Wayne P. Schammell, Ph.D.,
`states that in his experience “individuals working in the field often have BS
`or MS degrees with relevant experience in the field.” Ex. 2003 4 44. At his
`deposition, Dr. Martin acknowledged that a chemist with a master’s degree
`could beaskilled artisan “with appropriate experience,” and that one with a
`bachelor’s degree that focuses on organic chemistry and at least 10 years of
`experience could also be a skilled artisan. Ex. 1027, 112:21-114:1. We
`have also taken into account the level of skill in the art that is reflected in the
`
`prior art references themselves. See Okajima v. Bourdeau, 261 F3d 4350,
`135 (Fed. Cir. 2001). With regard to Petitioners’ contention as to whethera
`skilled artisan would have the knowledge and experience to understand
`whether a catalyst concentration is a result-effective variable (Reply 2), we
`determinethat issue is more appropriately considered as part ofthe
`substance of the obviousness analysis rather than our determination of the
`appropriate skill level for the ’921 patent.
`
`D. Analysis ofPetitioners’ Patentability Challenges
`
`Petitioners contend that claims 1—5 are obvious based on the teachings
`of the °732 publication in combination with RU °177 andthe 318
`application. Pet. 27-40. Petitioners additionally contend that claims 7—9 are
`obvious over the combination of the ’732 publication, RU °177, and the °318
`application in-further view of Lewkowski and Oae. Id. at 45-49.
`
`13
`
`
`
`IPR2015-01838 ©
`Patent 8,865,921 B2
`
`Independent claim 1 requires the preparation of FDCA by contacting a
`feed comprising HMF,orcertain derivatives of HMF, with an oxygen-
`containing gas in the presence of a Co/Mn/Broxidation catalyst, and an
`acetic acid-based solvent or solvent mixture, at a temperature between 140°C
`and 200°C, and at an oxygen partial pressure (pO2) of 1 to 10 bar. Ex. 1001,"
`7:60-8:6. Independentclaim 7 recites the same process of claim 1, and
`furtherrecites the additional step of “esterifying the thus obtained product”
`in order to produce a dialkyl ester of FDCA. Jd. at 9:1-14. Wefocus our
`analysis on these independent claims.
`.
`In ourInstitution Decision, we determined that Petitioners
`
`demonstrated a reasonable likelihood of prevailing with respect to these
`obviousness challenges based onthe preliminary recordat the time and
`instituted trial on that basis. Inst. Dec. 13-15, 18-19. We have now
`reconsidered the arguments and evidence presented with the Petition, along
`with-the additional arguments and evidence presented with Patent Owner’s
`Response andPetitioners’ Reply, underthe preponderanceofthe evidence
`standard applicable to Final Written Decisions in an inter partes review. 35
`
`U.S.C. § 316(e).
`Asan initial matter, we commenton Petitioners” attempts to apply the
`
`“prima facie” burden-shifting framework typically applied during patent
`examination to argue obviousnessin this proceeding. See, e.g. ,Pet. 8
`(“Thus, the claims of the °921 patent are primafacie rendered obviousin
`view of the ’732 publication because there is no evidence that reducing the
`oxygen partial pressure by 4.5 bar[]is critical to the methodsor process of
`oxidizing-HMF to FDCA.”); id. at 50 (asserting that “[a]primafacie case of
`obviousness exists where the claimed ranges andprior art ranges donot
`
`14
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`overlap but are close enough that one skifledin the art would have expected
`them to have the same properties”) (citing MPEP § 2 144.05); Reply 9
`(arguing that “[tJhis overlap [in temperature] alone supports a finding of a
`primafacie case of obviousness.”); id. at 14-15 (“Because the claimed
`ranges ‘overlap orlie inside ranges disclosed by the priorart,’ a primafacie
`case of obviousness exists.”). Based on thepriorart’s disclosure of broader
`or overlapping ranges,Petitioners seek to shift the burden to Patent Ownerto
`rebut their alleged prima facie case by showing “criticality” with the claimed
`ranges. See, e.g., Reply 9, 13, 21-23. The Federal Circuit has stated,
`however, that such a “burden-shifting framework does not apply in the
`adjudicatory context of an [inter partes review}.” In re Magnum Oil Tools
`Int'l, Ltd., 829 F.3d 1364, 1375-(Fed. Cir. 2016). Rather, “[i]n an inter
`partes review,the*burdenof persuasionis on the petitioner to prove
`‘unpatentability by a preponderanceof the evidence,’ 35 U.S.C. §316€e),
`and that burden nevershifts to the patentee.” Dynamic Drinkware, LLCv.
`Nat'l Graphics, Inc., 800 F.3d 1375, 1378 (Fed. Cir. 2015) (citation:
`
`omitted).
`TakingPetitioners’ burden of persuasion into account, we find that the
`evidence fails to show it would have been obvious to adjust both the
`temperature and pO> in the processestaught by the prior art to within the
`claimed ranges as a matter of routine optimization. We have also considered
`Patent Owner’s “objective evidence” conceming unexpectedresults,
`satisfaction of a long-felt but unmet need, and copying, butfind that
`evidenceto be lessprobative in supporting a conclusion of non-obviousness.
`Nonetheless, based upon ourconsideration ofthe record as a whole, we
`determine that Petitioners have not establishedthe unpatentability of claims
`
`15
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`1-5 and 7-9 by a preponderanceofthe evidence. We address these issues
`
`separately in further detail below.
`
`1. Optimization ofTemperature to Between 140° and 200°C
`and Oxygen Partial Pressure to Between 1 and 10 Bar
`
`Although the prior art disclosed processes with broaderor overlapping
`temperature or pressure ranges, none ofthe references relied upon by
`Petitioners expressly taught a process in which HME orits derivatives were
`oxidized to FDCA using a‘Co/Mn/Brcatalyst at a reaction temperature of
`between 140°C and 200°C while also maintaining the pO2 between | and 10
`
`bar as required by the challenged claimsof the °921 patent. Petitioners,
`therefore, rely upon an “optimization” rationale to assert that the claimed-
`invention would have been obvious. See, e.g., Pet. 9 (“[V]ariations in
`temperature and pressure are nothing more than the optimization of
`oxidation conditions explicitly suggested by the.’732 publication...
`Conducting routine experimentation to determine optimal or workable
`ranges that produce expectedresults is suggested to one ofordinary skill in
`
`the-art by the ’732 publication.”).
`It is well-established that “where the general conditions of a claim are
`disclosedin the priorart, it is not inventive to discover the optimum or
`workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456
`(CCPA 1955). However, the parameter to be optimized must have been
`recognized bythose skilled in the art to be a “result-effective variable.” Jn
`re Antonie, 559 F.2d 618, 620 (CCPA 1977). ‘While the absence of any
`disclosure regarding the relationship between the variable and the affected
`property mayprecludea findingthat the variable is result-effective,the prior
`art need not provide the exact method ofoptimization for the variable to be
`
`16
`
`
`
`IPR2015-01838
`Patent 8,865,921 B2
`
`result-effective.” In re Applied Materials, Inc., 692 F.3d 1289, 1297 {Fed.
`Cir. 2012). Rather, “{a] recognition in the prior art that a property is affected
`by the variable is sufficient to find the variable result-effective.” Id.
`Moreover, where multiple result-effective variables are combined,
`“elvidence that the variables interacted in an unpredictable or unexpected
`way could render the combination nonobvious.” Jd. at 1298 (citing ASR
`Int’l Co. v. Teleflex Inc., 550 U.S. 398, 421 (2007)). Applying these
`principles, wefind that Petitioners have not demonstrated that itwould have
`been a matter of routine experimentation to optimize the reaction
`temperature and pO>asresult-effective variables.
`Petitioners contend that “the ’732 publication suggested to a person of
`ordinary. skill in the art to vary residence time, temperature and pressure to
`withinthe claim